Does EMPAGLIFLOZIN Cause Hypovolaemia? 150 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 150 reports of Hypovolaemia have been filed in association with EMPAGLIFLOZIN (Jardiance). This represents 0.4% of all adverse event reports for EMPAGLIFLOZIN.
150
Reports of Hypovolaemia with EMPAGLIFLOZIN
0.4%
of all EMPAGLIFLOZIN reports
7
Deaths
107
Hospitalizations
How Dangerous Is Hypovolaemia From EMPAGLIFLOZIN?
Of the 150 reports, 7 (4.7%) resulted in death, 107 (71.3%) required hospitalization, and 20 (13.3%) were considered life-threatening.
Is Hypovolaemia Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for EMPAGLIFLOZIN. However, 150 reports have been filed with the FAERS database.
What Other Side Effects Does EMPAGLIFLOZIN Cause?
Diabetic ketoacidosis (3,644)
Fungal infection (1,941)
Blood glucose increased (1,797)
Euglycaemic diabetic ketoacidosis (1,769)
Weight decreased (1,661)
Urinary tract infection (1,439)
Ketoacidosis (1,411)
Dizziness (1,372)
Nausea (1,333)
Vomiting (1,201)
What Other Drugs Cause Hypovolaemia?
FUROSEMIDE (346)
METFORMIN (281)
SPIRONOLACTONE (123)
DEXAMETHASONE (117)
HYDROCHLOROTHIAZIDE (94)
PREDNISONE (91)
LISINOPRIL (86)
METOPROLOL (84)
ACETAMINOPHEN (77)
SACUBITRIL\VALSARTAN (73)
Which EMPAGLIFLOZIN Alternatives Have Lower Hypovolaemia Risk?
EMPAGLIFLOZIN vs EMPAGLIFLOZIN\LINAGLIPTIN
EMPAGLIFLOZIN vs EMPAGLIFLOZIN\LINAGLIPTIN\METFORMIN
EMPAGLIFLOZIN vs EMPAGLIFLOZIN\METFORMIN
EMPAGLIFLOZIN vs EMSAM
EMPAGLIFLOZIN vs EMTRICITABINE